In 2021, Ride for Cancer powered by BMO Bank of Montreal is leading the charge to introduce new genetic sequencing technology at the QEII Health Sciences Centre that will be used to analyze the genes of tumour samples. This will help identify the most targeted and effective treatments for cancer patients based on their tumour genetic makeup and unique cancer type.
With more than 200 different types of cancer, no two tumors or diagnoses are exactly alike.
But with this genetic sequencing technology, the QEII can unlock a personalized treatment plan by knowing how an individual’s cancer might progress and the treatment it may best respond to.
Better outcomes, fewer side effects, access to a new therapy or clinical trial are all benefits this technology brings to patients, here at home. It can even spare patients from unnecessary treatments, if care teams know their cancer won’t respond. This is particularly important to those facing late-stage cancers.
When you join our Ride community, you help cancer patients at the QEII receive more personalized treatment options than ever before, as we continue to build a true centre of excellence for cancer care at the QEII.